Fitz A E, Saunders E
J Cardiovasc Pharmacol. 1981;3 Suppl 2:S85-91.
Efficacy and dosage data were analyzed for patients who received methyldopa up to 4.5 years. A prompt initial response to methyldopa was observed, and the blood pressure reduction was maintained throughout the follow-up period. Mean dosage rose modestly during this time.